Education
About Us
Working with TipRanks
Follow Us
Vincerx Pharma Inc (VINC)
NASDAQ:VINC
See the Price Targets and Ratings of:
VINC Financial Forecast
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Leerink Partners
$2
Buy
83.49%
Upside
Reiterated
11/12/24
Vincerx Pharma Inc: Strategic Advancements and Promising Pipeline Highlight Buy Rating
Best Analysts Covering Vincerx Pharma Inc
Which Analyst Should I Follow If I Want to Buy VINC and Sell After:
1 Month
xxx
Success Rate
6/19 ratings generated profit
Average Return
-9.10%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 31.58% of your transactions generating a profit, with an average return of -9.10% per trade.
3 Months
xxx
Success Rate
4/19 ratings generated profit
Average Return
+13.11%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 21.05% of your transactions generating a profit, with an average return of +13.11% per trade.
1 Year
Success Rate
1/19 ratings generated profit
Average Return
-39.63%
reiterated a buy rating 4 months ago
Copying Jonathan Chang's trades and holding each position for 1 Year would result in 5.26% of your transactions generating a profit, with an average return of -39.63% per trade.
2 Years
xxx
Success Rate
2/19 ratings generated profit
Average Return
-74.02%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 10.53% of your transactions generating a profit, with an average return of -74.02% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
VINC Analyst Recommendation Trends
Rating
Apr 24
May 24
Aug 24
Oct 24
Nov 24
Strong Buy
0
0
0
0
0
Buy
3
3
3
3
3
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
3
3
3
Each month's total comprises the sum of three months' worth of ratings.
VINC Stock Forecast FAQ
What is VINC’s average 12-month price target, according to analysts?
Based on analyst ratings, Vincerx Pharma Inc’s 12-month average price target is $2.00.
What is VINC’s upside potential, based on the analysts’ average price target?
Vincerx Pharma Inc has 83.49% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is VINC a Buy, Sell or Hold?
Vincerx Pharma Inc has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Vincerx Pharma Inc’s price target?
The average price target for Vincerx Pharma Inc is $2.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $2.00 ,the lowest forecast is $2.00. The average price target represents 83.49% Increase from the current price of $1.09.
The highest analyst price target is $2.00 ,the lowest forecast is $2.00. The average price target represents 83.49% Increase from the current price of $1.09.
What do analysts say about Vincerx Pharma Inc?
Vincerx Pharma Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of VINC?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.